Literature DB >> 6641746

The idiopathic long QT syndrome: the need for a prospective registry.

P J Schwartz.   

Abstract

The pathogenetic mechanisms of idiopathic long QT syndrome have been largely, although not completely, understood; however, several critical issues highly relevant to the clinical management of patients affected by the syndrome need to be clarified. For this purpose, physicians are invited to a registry of such patients.

Entities:  

Mesh:

Year:  1983        PMID: 6641746     DOI: 10.1093/oxfordjournals.eurheartj.a061517

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

1.  Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.

Authors:  Lia Crotti; Carla Spazzolini; David J Tester; Alice Ghidoni; Alban-Elouen Baruteau; Britt-Maria Beckmann; Elijah R Behr; Jeffrey S Bennett; Connie R Bezzina; Zahurul A Bhuiyan; Alpay Celiker; Marina Cerrone; Federica Dagradi; Gaetano M De Ferrari; Susan P Etheridge; Meena Fatah; Pablo Garcia-Pavia; Saleh Al-Ghamdi; Robert M Hamilton; Zuhair N Al-Hassnan; Minoru Horie; Juan Jimenez-Jaimez; Ronald J Kanter; Juan P Kaski; Maria-Christina Kotta; Najim Lahrouchi; Naomasa Makita; Gabrielle Norrish; Hans H Odland; Seiko Ohno; John Papagiannis; Gianfranco Parati; Nicole Sekarski; Kristian Tveten; Matteo Vatta; Gregory Webster; Arthur A M Wilde; Julianne Wojciak; Alfred L George; Michael J Ackerman; Peter J Schwartz
Journal:  Eur Heart J       Date:  2019-09-14       Impact factor: 29.983

Review 2.  Assessment of the risk-benefit ratio for antiarrhythmic drug use.

Authors:  R W Campbell
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

3.  Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.

Authors:  Sami Viskin; Arthur A M Wilde; Hanno L Tan; Charles Antzelevitch; Wataru Shimizu; Bernard Belhassen
Journal:  Heart Rhythm       Date:  2008-12-03       Impact factor: 6.343

Review 4.  Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?

Authors:  Domenico Corrado; Mark S Link; Peter J Schwartz
Journal:  Eur Heart J       Date:  2022-08-21       Impact factor: 35.855

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.